QuanDx
QuanDx is a molecular diagnostics pioneer developing technologies and products for a variety of clinical applications, including leukemia fusion gene detection and infectious disease testing. The company focuses on innovative solutions such as the Q-Fusion multiplex system, Yin-Yang probes, and high-risk HPV genotyping assays, aiming to provide rapid, simple, and cost-effective diagnostic tools. QuanDx is committed to advancing personalized cancer treatment and infectious disease diagnostics.
Industries
Nr. of Employees
small (1-50)
QuanDx
2176 Ringwood Avenue, San Jose, CA 95131, USA
Patents
Products
Leukemia fusion gene screening kit (multiplex)
Multiplex screening kit for simultaneous detection of multiple leukemia-associated fusion genes to support diagnosis and monitoring.
Fusion gene genotyping and quantification kits (qPCR)
qPCR-based genotyping and quantification kits targeting specific fusion transcripts (examples include BCR-ABL1 and PML-RARα).
High-risk HPV genotyping assay (14-type, single-tube, dry format)
PCR-based high-risk HPV genotyping assay that identifies 14 HPV types in a single-tube reaction using melting-curve analysis; provided in a dry format to simplify shipping and storage and with automated result interpretation.
Automated magnetic bead-based nucleic acid extraction system
Bench-top system using magnetic-bead chemistry for automated isolation and purification of nucleic acids; supports up to 24 samples per run, sample volumes 1–2000 µL, and processing times of ~20–40 minutes.
Leukemia fusion gene screening kit (multiplex)
Multiplex screening kit for simultaneous detection of multiple leukemia-associated fusion genes to support diagnosis and monitoring.
Fusion gene genotyping and quantification kits (qPCR)
qPCR-based genotyping and quantification kits targeting specific fusion transcripts (examples include BCR-ABL1 and PML-RARα).
High-risk HPV genotyping assay (14-type, single-tube, dry format)
PCR-based high-risk HPV genotyping assay that identifies 14 HPV types in a single-tube reaction using melting-curve analysis; provided in a dry format to simplify shipping and storage and with automated result interpretation.
Automated magnetic bead-based nucleic acid extraction system
Bench-top system using magnetic-bead chemistry for automated isolation and purification of nucleic acids; supports up to 24 samples per run, sample volumes 1–2000 µL, and processing times of ~20–40 minutes.
Services
Regional distribution and commercial placement of molecular diagnostic IVD assays, including support for ordering and sales.
Customer technical support and product inquiry channels for instruments and assays via phone and email.
Regional distribution and commercial placement of molecular diagnostic IVD assays, including support for ordering and sales.
Customer technical support and product inquiry channels for instruments and assays via phone and email.
Expertise Areas
- Molecular diagnostics development
- Assay design and multiplexing
- Melting-curve based genotyping
- Automated nucleic acid extraction
Key Technologies
- Melting curve analysis
- Multiplex PCR
- Custom probe-based multiplexing
- Magnetic bead nucleic acid extraction
News & Updates
American Society for Microbiology, Boston, MA, June 16-20, 2016, Booth 623
European Research Organisation on Genital Infection and Neoplasia, Salzburg, Austria, June 15-18, 2016, Booth 7
Chicago, IL, June 3-7, Booth 25088
Daytona Beach, FL, May 19-22, 2016, Booth 438
Amsterdam, Netherlands, April 9-12, 2016
Unexpected Prevalence of Rare High-Risk HPV Types Demonstrates Utility of Zeesan Biotech Assay in Low-Resource Setting May 29, 2019 | Madeleine Johnson
American Society for Microbiology, Boston, MA, June 16-20, 2016, Booth 623
European Research Organisation on Genital Infection and Neoplasia, Salzburg, Austria, June 15-18, 2016, Booth 7
Chicago, IL, June 3-7, Booth 25088
Daytona Beach, FL, May 19-22, 2016, Booth 438
Amsterdam, Netherlands, April 9-12, 2016
Unexpected Prevalence of Rare High-Risk HPV Types Demonstrates Utility of Zeesan Biotech Assay in Low-Resource Setting May 29, 2019 | Madeleine Johnson